94 related articles for article (PubMed ID: 17728606)
1. Validation of a resolution-independent method for the quantification of 123I-FP-CIT SPECT scans.
Goethals I; Dobbeleir A; Ham H; Santens P; D'Asseler Y
Nucl Med Commun; 2007 Oct; 28(10):771-4. PubMed ID: 17728606
[TBL] [Abstract][Full Text] [Related]
2. Global scaling for semi-quantitative analysis in FP-CIT SPECT.
Kupitz D; Apostolova I; Lange C; Ulrich G; Amthauer H; Brenner W; Buchert R
Nuklearmedizin; 2014; 53(6):234-41. PubMed ID: 25209576
[TBL] [Abstract][Full Text] [Related]
3. Assessing the accuracy and reproducibility of computer-assisted analysis of (123) I-FP-CIT SPECT using BasGan (V2).
Skanjeti A; Angusti T; Iudicello M; Dazzara F; Delgado Yabar GM; Trevisiol E; Podio V
J Neuroimaging; 2014; 24(3):257-65. PubMed ID: 23323544
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Reconstruction Strategies for the Quantification and Diagnostic Accuracy of (123)I-FP-CIT SPECT].
Kameiyama H; Matsutomo N; Nagaki A; Yamao F
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 Jul; 72(7):595-601. PubMed ID: 27440703
[TBL] [Abstract][Full Text] [Related]
5. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M
Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT.
Stokkel MP; Dibbets-Schneider P; Koestering E; Dragoiescu C; Blokland KA
J Nucl Med Technol; 2007 Mar; 35(1):21-6. PubMed ID: 17337653
[TBL] [Abstract][Full Text] [Related]
7. Combined visual and semi-quantitative assessment of
Ueda J; Yoshimura H; Shimizu K; Hino M; Kohara N
Neurol Sci; 2017 Jul; 38(7):1187-1191. PubMed ID: 28389938
[TBL] [Abstract][Full Text] [Related]
8. Use of the BasGan algorithm for [123I]FP-CIT SPECT quantification: a phantom study.
Poli GL; Bianchi C; Guerra UP
Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):391-400. PubMed ID: 23752689
[TBL] [Abstract][Full Text] [Related]
9. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
Koch W; Radau PE; Hamann C; Tatsch K
J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
[TBL] [Abstract][Full Text] [Related]
10. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
11. 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.
Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
Nucl Med Commun; 2006 Apr; 27(4):381-6. PubMed ID: 16531926
[TBL] [Abstract][Full Text] [Related]
12. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
[TBL] [Abstract][Full Text] [Related]
13. Affine registration of [123I]FP-CIT SPECT brain images.
Salas-Gonzalez D; Górriz JM; Ramírez J; A Illán I; Padilla P; Martínez-Murcia FJ; Lang EW
Stud Health Technol Inform; 2014; 207():65-73. PubMed ID: 25488212
[TBL] [Abstract][Full Text] [Related]
14. A robust computational solution for automated quantification of a specific binding ratio based on [123i]fp-cit SPECT images.
Oliveira FP; Borges Faria D; Campos Costa D; Tavares JM
Q J Nucl Med Mol Imaging; 2014 Mar; 58(1):74-84. PubMed ID: 24145318
[TBL] [Abstract][Full Text] [Related]
15. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
[TBL] [Abstract][Full Text] [Related]
16. Semiquantitative slab view display for visual evaluation of 123I-FP-CIT SPECT.
Buchert R; Hutton C; Lange C; Hoppe P; Makowski M; Bamousa T; Platsch G; Brenner W; Declerck J
Nucl Med Commun; 2016 May; 37(5):509-18. PubMed ID: 26703759
[TBL] [Abstract][Full Text] [Related]
17. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.
Hauser RA; Grosset DG
J Neuroimaging; 2012 Jul; 22(3):225-30. PubMed ID: 21410815
[TBL] [Abstract][Full Text] [Related]
18. Interobserver variability, and visual and quantitative parameters of (123)I-FP-CIT SPECT (DaTSCAN) studies.
Papathanasiou N; Rondogianni P; Chroni P; Themistocleous M; Boviatsis E; Pedeli X; Sakas D; Datseris I
Ann Nucl Med; 2012 Apr; 26(3):234-40. PubMed ID: 22237674
[TBL] [Abstract][Full Text] [Related]
19. Visual versus automated analysis of [I-123]FP-CIT SPECT scans in parkinsonism.
Mäkinen E; Joutsa J; Johansson J; Mäki M; Seppänen M; Kaasinen V
J Neural Transm (Vienna); 2016 Nov; 123(11):1309-1318. PubMed ID: 27324804
[TBL] [Abstract][Full Text] [Related]
20. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Benamer TS; Patterson J; Grosset DG; Booij J; de Bruin K; van Royen E; Speelman JD; Horstink MH; Sips HJ; Dierckx RA; Versijpt J; Decoo D; Van Der Linden C; Hadley DM; Doder M; Lees AJ; Costa DC; Gacinovic S; Oertel WH; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
Mov Disord; 2000 May; 15(3):503-10. PubMed ID: 10830416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
